Awarded by the Rabelais Foundation, VitamFero received the Indre & Loire Top Companies 2011 Trophy for Best Innovation

January 16, 2012

VitamFero and Oniris have signed an agreement to study the efficacy of a vaccine candidate against neosporosis at a major centre for preclinical studies, the Oniris CRIP

November 30, 2011

VitamFero announces the issuance of key patents covering new antiparasitic vaccines in the USA, Japan, Australia and New Zealand

October 17, 2011

Cellectis and VitamFero Collaborate to Develop Vaccines against Parasitic Infection

June 6, 2011

VitamFero, a Genopole® accredited company, closes its initial round of financing with venture capitalists

February 22, 2011

VitamFero, a Genopole® accredited company, closes its initial round of financing with venture capitalists

http://www.vitamfero.com/public/communiques/22-2-11_Round_of_financing.pdf

Pages : 1 2 3 4